Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Hepatocyte growth factor inhibits TGF-β1-induced myofibroblast differentiation in tendon fibroblasts: role of AMPK signaling pathway.

Cui Q, Fu S, Li Z.

J Physiol Sci. 2013 May;63(3):163-70. doi: 10.1007/s12576-013-0251-1. Epub 2013 Feb 1.

PMID:
23371911
2.

HGF inhibits TGF-β1-induced myofibroblast differentiation and ECM deposition via MMP-2 in Achilles tendon in rat.

Cui Q, Wang Z, Jiang D, Qu L, Guo J, Li Z.

Eur J Appl Physiol. 2011 Jul;111(7):1457-63. doi: 10.1007/s00421-010-1764-4. Epub 2010 Dec 17.

PMID:
21165643
3.

Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.

Sobral LM, Montan PF, Zecchin KG, Martelli-Junior H, Vargas PA, Graner E, Coletta RD.

J Periodontol. 2011 Apr;82(4):642-51. doi: 10.1902/jop.2010.100510. Epub 2010 Nov 8.

PMID:
21054221
5.

Glycogen synthase kinase-3 (GSK-3) regulates TGF-β₁-induced differentiation of pulmonary fibroblasts.

Baarsma HA, Engelbertink LH, van Hees LJ, Menzen MH, Meurs H, Timens W, Postma DS, Kerstjens HA, Gosens R.

Br J Pharmacol. 2013 Jun;169(3):590-603. doi: 10.1111/bph.12098.

6.

CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.

Wu D, Lei H, Wang JY, Zhang CL, Feng H, Fu FY, Li L, Wu LL.

J Mol Med (Berl). 2015 Dec;93(12):1311-25. doi: 10.1007/s00109-015-1309-8. Epub 2015 Jul 3.

PMID:
26138247
8.

FAK activity is required for HGF to suppress TGF-β1-induced cellular proliferation.

Zhao Z, Sun Y, Yang S, Cui Q, Li Z.

In Vitro Cell Dev Biol Anim. 2015 Oct;51(9):941-9. doi: 10.1007/s11626-015-9914-y. Epub 2015 Apr 22.

PMID:
25898827
9.
10.

Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.

Chen LX, Yang K, Sun M, Chen Q, Wang ZH, Hu GY, Tao LJ.

Pharmazie. 2012 May;67(5):452-6.

PMID:
22764581
11.

The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts.

Chen KH, Hsu HH, Lee CC, Yen TH, Ko YC, Yang CW, Hung CC.

PLoS One. 2014 Sep 4;9(9):e106554. doi: 10.1371/journal.pone.0106554. eCollection 2014.

12.

C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.

Lei H, Wu D, Wang JY, Li L, Zhang CL, Feng H, Fu FY, Wu LL.

Basic Res Cardiol. 2015;110(4):35. doi: 10.1007/s00395-015-0492-7. Epub 2015 May 12.

PMID:
25962701
13.

Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.

Cho JS, Moon YM, Park IH, Um JY, Moon JH, Park SJ, Lee SH, Kang HJ, Lee HM.

Clin Exp Allergy. 2012 Jun;42(6):872-82. doi: 10.1111/j.1365-2222.2011.03931.x.

PMID:
22239687
14.

Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.

Peng H, Carretero OA, Peterson EL, Rhaleb NE.

Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1357-64. doi: 10.1152/ajpheart.00464.2009. Epub 2010 Feb 12.

15.

A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.

Yang J, Dai C, Liu Y.

J Am Soc Nephrol. 2005 Jan;16(1):68-78. Epub 2004 Nov 10.

16.

Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta.

Zhang YG, Hu YC, Mao YY, Wei RH, Bao SL, Wu LB, Kuang ZJ.

Chin Med J (Engl). 2010 Dec;123(24):3634-9.

PMID:
22166643
17.

Opposite effects of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival cell cultures.

Sobral LM, Montan PF, Martelli-Junior H, Graner E, Coletta RD.

J Clin Periodontol. 2007 May;34(5):397-406. Epub 2007 Apr 2.

PMID:
17403017
18.
19.

Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts.

Lu J, Shi J, Li M, Gui B, Fu R, Yao G, Duan Z, Lv Z, Yang Y, Chen Z, Jia L, Tian L.

Life Sci. 2015 Apr 15;127:59-65. doi: 10.1016/j.lfs.2015.01.042. Epub 2015 Mar 2.

PMID:
25744403
20.

Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.

Zhang A, Wang MH, Dong Z, Yang T.

Am J Physiol Renal Physiol. 2006 Dec;291(6):F1323-31. Epub 2006 Jul 25.

Supplemental Content

Support Center